DUPONT CAPITAL MANAGEMENT CORP - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 186 filers reported holding HERON THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.6%.

Quarter-by-quarter ownership
DUPONT CAPITAL MANAGEMENT CORP ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$102,000
-54.9%
24,221
+14.5%
0.01%
-14.3%
Q3 2021$226,000
-39.7%
21,153
-12.4%
0.01%
-22.2%
Q2 2021$375,000
-4.1%
24,1430.0%0.01%0.0%
Q1 2021$391,000
-36.5%
24,143
-17.0%
0.01%
-30.8%
Q4 2020$616,000
+33.0%
29,095
-6.9%
0.01%
+30.0%
Q3 2020$463,000
-5.7%
31,267
-6.3%
0.01%
-9.1%
Q2 2020$491,000
+15.0%
33,361
-8.2%
0.01%
+10.0%
Q1 2020$427,000
-50.0%
36,3400.0%0.01%
-47.4%
Q4 2019$854,00036,3400.02%
Other shareholders
HERON THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
TANG KEVIN C 760$1,900100.00%
Velan Capital Investment Management LP 2,500,000$6,250,0005.52%
GREAT POINT PARTNERS LLC 6,360,161$15,900,4033.12%
Cheyne Capital Management (UK) LLP 318,008$795,0201.39%
TANG CAPITAL MANAGEMENT LLC 3,755,934$9,389,8351.36%
Rubric Capital Management LP 11,750,000$29,375,0001.28%
Orchard Capital Management, LLC 1,391,080$3,477,7001.17%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 267,028$667,5700.81%
CM Management, LLC 250,000$6250.75%
Tejara Capital Ltd 493,619$1,234,0480.71%
View complete list of HERON THERAPEUTICS INC shareholders